VCAM1 and COVID-19: Soluble forms of ICAM-1, VCAM-1 and E-selectin are used as biomarkers for endothelial cell activation, and several studies demonstrate increased concentrations of these proteins in COVID-19 patients related to the disease severity (19–21).